Luca Iuzzolino

ORCID: 0000-0001-9241-6828
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Crystallography and molecular interactions
  • Computational Drug Discovery Methods
  • Enzyme Structure and Function
  • Chemical Thermodynamics and Molecular Structure
  • Machine Learning in Materials Science
  • Biochemical and Molecular Research
  • HIV/AIDS drug development and treatment
  • Drug Solubulity and Delivery Systems
  • Mathematical and Theoretical Epidemiology and Ecology Models
  • DNA and Nucleic Acid Chemistry
  • Protein purification and stability
  • Porphyrin Metabolism and Disorders
  • Molecular spectroscopy and chirality
  • Carbohydrate Chemistry and Synthesis
  • Analytical Methods in Pharmaceuticals
  • thermodynamics and calorimetric analyses
  • Synthesis and biological activity
  • Tuberculosis Research and Epidemiology
  • Plant biochemistry and biosynthesis
  • Metal-Organic Frameworks: Synthesis and Applications
  • Chemical Synthesis and Analysis

Merck & Co., Inc., Rahway, NJ, USA (United States)
2021-2025

University College London
2016-2018

Anthony M. Reilly Richard I. Cooper Claire S. Adjiman Saswata Bhattacharya A. Daniel Boese and 87 more Jan Gerit Brandenburg Peter J. Bygrave Rita Bylsma Josh E. Campbell Roberto Car David H. Case Renu Chadha Jason C. Cole Katherine Cosburn H. M. Cuppen Farren Curtis Graeme M. Day Robert A. DiStasio Alexander Dzyabchenko Bouke P. van Eijck Dennis M. Elking Joost A. van den Ende Julio C. Facelli Marta B. Ferraro László Füsti-Molnár Christina-Anna Gatsiou Thomas S. Gee R. De Gelder Luca M. Ghiringhelli Midori Goto Stefan Grimme Rui Guo Detlef W. M. Hofmann Johannes Hoja Rebecca K. Hylton Luca Iuzzolino Wojciech Jankiewicz Daniël T. De Jong John Kendrick Niek J. J. de Klerk Hsin-Yu Ko L. N. Kuleshova Xiayue Li Sanjaya Lohani Frank J. J. Leusen Albert M. Lund Jian Lv Yanming Ma Noa Marom Artëm E. Masunov Patrick McCabe David P. McMahon Hugo Meekes Michael P. Metz Alston J. Misquitta Sharmarke Mohamed Bartomeu Monserrat R. J. Needs Marcus A. Neumann Jonas Nyman Shigeaki Obata Harald Oberhofer Artem R. Oganov Anita M. Orendt Gabriel I. Pagola Constantinos C. Pantelides Chris J. Pickard Rafał Podeszwa Louise S. Price Sarah L. Price Angeles Pulido Murray G. Read Karsten Reuter Elia Schneider Christoph Schober G.P. Shields Pawanpreet Singh Isaac J. Sugden Krzysztof Szalewicz Christopher R. Taylor Alexandre Tkatchenko Mark E. Tuckerman Francesca Vacarro Manolis Vasileiadis Álvaro Vázquez‐Mayagoitia Leslie Vogt-Maranto Yanchao Wang Rona E. Watson G. A. de Wijs Jack Yang Qiang Zhu Colin R. Groom

The sixth blind test of organic crystal structure prediction (CSP) methods has been held, with five target systems: a small nearly rigid molecule, polymorphic former drug candidate, chloride salt hydrate, co-crystal and bulky flexible molecule. This seen substantial growth in the number participants, broad range giving unique insight into state art field. Significant progress treating molecules, usage hierarchical approaches to ranking structures, application density-functional...

10.1107/s2052520616007447 article EN cc-by Acta Crystallographica Section B Structural Science Crystal Engineering and Materials 2016-08-01

A combined experimental NMR and DFT computational analysis of molnupiravir, an orally dosed antiviral effective for treatment patients with COVID-19, determined that the molecule primarily exists as oxime tautomer both in solution solid state. Both Z E stereoisomers were observed various solvents, being major form, consistent calculations. An amine form was not detected directly, but results strongly suggest it transient intermediate responsible interconversion isomers solution. The...

10.26434/chemrxiv-2025-jnmn1 preprint EN cc-by-nc-nd 2025-01-16

Periodic DFTB3-D3 calculations allow the refinement of molecular conformations within crystal structures and estimates phonons for flexible pharmaceutical molecules.

10.1039/c8fd00010g article EN cc-by Faraday Discussions 2018-01-01

Crystal structure prediction (CSP) is an invaluable tool in the pharmaceutical industry because it allows to predict all possible crystalline solid forms of small-molecule active ingredients. We have used a CSP-based cocrystal method rank ten potential coformers by energy cocrystallization reaction with antiviral drug candidate, MK-8876, and triol process intermediate, 2-ethynylglyclerol. For was performed retrospectively successfully predicted maleic acid as most likely be observed. The...

10.1021/acs.molpharmaceut.2c01098 article EN Molecular Pharmaceutics 2023-06-06

Crystalline suspensions of monoclonal antibodies (mAbs) have great potential to improve drug substance isolation and purification on a large scale be used for delivery via high-concentration formulations. mAb are expected enhanced chemical physical properties relative solutions delivered intravenously, making them attractive candidates subcutaneous delivery. In contrast small molecules, the development protein crystalline is not widely approach in pharmaceutical industry. This mainly due...

10.1021/acs.molpharmaceut.4c00418 article EN Molecular Pharmaceutics 2024-07-03

We report the process development for active pharmaceutical ingredient (API) step of commercial manufacturing route to nemtabrutinib (MK-1026), a reversible Bruton’s Tyrosine Kinase (BTK) inhibitor currently under investigation treatment several hematological malignancies. Significant improvements on efficiency were achieved by direct isolation leveraging optimal reaction conditions and synergistic API solubility in an ethanol/water system. In combination with additional robustness impurity...

10.1021/acs.oprd.2c00391 article EN Organic Process Research & Development 2023-03-10

Although the crystal structures of small-molecule compounds are often determined from single-crystal X-ray diffraction (scXRD), recent advances in three-dimensional electron (3DED) and structure prediction (CSP) methods promise to expand elucidation toolbox available crystallographer. Herein, a comparative assessment scXRD, 3DED, CSP combination with powder is carried out on two former drug candidate multicomponent key building block synthesis gefapixant citrate.

10.1021/acs.molpharmaceut.2c00020 article EN cc-by-nc-nd Molecular Pharmaceutics 2022-05-16

Determining the range of conformations that a flexible pharmaceutical-like molecule could plausibly adopt in crystal structure is key to successful prediction (CSP) studies. We aim use conformational information from structures Cambridge Structural Database (CSD) facilitate this task. The produced by CSD Conformer Generator are reduced number considering underlying rotamer distributions, an analysis changes molecular shape, and minimal ab initio calculations. This method tested for five...

10.1021/acs.jctc.7b00623 article EN Journal of Chemical Theory and Computation 2017-09-11

Amorphous solid dispersions (ASDs) are a well-documented formulation approach to improve the rate and extent of dissolution for hydrophobic pharmaceuticals. However, weakly basic compounds can complicate standard approaches ASDs due pH-dependent solubility, resulting in uncontrolled drug release gastric conditions unstabilized supersaturated solutions prone precipitation at neutral pH. This work examines mechanisms amorphous containing model pharmaceuticals posaconazole lumefantrine from...

10.1021/acs.molpharmaceut.2c00456 article EN Molecular Pharmaceutics 2022-08-19

Crystal polymorphism, characterized by different packing arrangements of the same compound, strongly ties to physical properties a molecule. Determining polymorphic landscape is complex and time-consuming, with number experimentally observed polymorphs varying widely from molecule Furthermore, disappearing polymorphs, phenomenon whereby forms cannot be reproduced, pose significant challenge for pharmaceutical industry. Herein, we focused on oxindole (OX), small rigid four known including...

10.1002/anie.202406214 article EN Angewandte Chemie International Edition 2024-06-03

Solid form screens of active pharmaceutical ingredients are a key component drug development. Beyond forming multiple neat crystal structures, also known as polymorphs, drugs can crystallize with variety solvent molecules to solvates. They display physiochemical properties different from the solid selected for Hence, using computational structure prediction (CSP) methods predict formation solvates would be valuable industry. However, CSP solvate faces range obstacles. This work addresses two...

10.1021/acs.cgd.1c00265 article EN Crystal Growth & Design 2021-07-14

Abstract Crystal polymorphism, characterized by different packing arrangements of the same compound, strongly ties to physical properties a molecule. Determining polymorphic landscape is complex and time‐consuming, with number experimentally observed polymorphs varying widely from molecule Furthermore, disappearing polymorphs, phenomenon whereby forms cannot be reproduced, pose significant challenge for pharmaceutical industry. Herein, we focused on oxindole (OX), small rigid four known...

10.1002/ange.202406214 article EN Angewandte Chemie 2024-06-03

This article reports a rare example of the crystallization cocrystal an organic molecule with its epimer. In this case, belzutifan, novel treatment for von Hippel–Lindau (VHL) disease-associated renal cell carcinoma (RCC), crystallizes as 1:1 one epimers (inversion stereochemistry at hydroxyl position). observation is particular importance to controlling purity API in commercial manufacturing process. After discovery cocrystal, crystalline structure was determined through combination crystal...

10.1021/acs.oprd.3c00195 article EN Organic Process Research & Development 2023-08-31

During large-scale crystallization of the ethyl ester (EE) starting material Doravirine (MK-1439) (Huang et al. ACS Infectious Dis. 2020, 6, 64–73) four out nine batches exhibited unique infrared spectra upon release testing and atypical powder X-ray diffraction (PXRD) patterns not conforming to target crystalline phase, Form 1. This work presents investigations triggered within MSD's laboratories on polymorphism EE strategy employed for identifying nature form impurity understanding its...

10.1021/acs.cgd.1c00469 article EN Crystal Growth & Design 2021-06-14

10.1107/s2053273323098820 article EN Acta Crystallographica Section A Foundations and Advances 2023-07-07

10.1107/s2053273323098571 article EN Acta Crystallographica Section A Foundations and Advances 2023-07-07
Coming Soon ...